Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuntao Liu

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell LeukemogenesisZhaojing Wang, Yufeng Hu, Daibiao Xiao, et al.
The World Allergy Organization Journal|October 6, 2021
Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a <i>post-hoc</i> analysis of a randomised phase III studyJing Li, Changzheng Wang, Chuntao Liu, et al.
Peerj|April 13, 2023
T cell receptor repertoire as a novel indicator for identification and immune surveillance of patients with severe obstructive sleep apneaKai Li, Yue Zhuo, Yue He, et al.
IEEE Journal of Biomedical and Health Informatics|August 20, 2024
3MT-Net: A Multi-modal Multi-task Model for Breast Cancer and Pathological Subtype Classification Based on a Multicenter StudyYaofei Duan, Patrick Cheong-Iao Pang, Ping He, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A <i>Post-hoc</i> Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled TrialRuchong Chen, Yuanrong Dai, Danrong Yang, et al.
Journal of Thoracic Disease|May 22, 2025
The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024]Nan Jia, Meiling Jin, Yun Liu, et al.
Plos One|January 13, 2021
Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, ChinaAlastair Heffernan, Yanling Ma, Shevanthi Nayagam, et al.
Journal of Gastroenterology|July 29, 2025
The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancerFeng Du, Xu Ji, Jiayi Su, et al.
BMC Infectious Diseases|August 10, 2021
Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, ChinaJianjiang Qi, Di He, Dagan Yang, et al.
QJM : Monthly Journal of the Association of Physicians|December 31, 2025
Efficacy and Safety of Intranasal Bencycloquidium Bromide in Nasal Symptoms of Common Cold: a Phase 3, Multicenter, Randomised, Double-blind, Placebo-controlled TrialLixiu He, Ling Yang, Haiying Yan, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell LeukemogenesisZhaojing Wang, Yufeng Hu, Daibiao Xiao, et al.
The World Allergy Organization Journal|October 6, 2021
Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a <i>post-hoc</i> analysis of a randomised phase III studyJing Li, Changzheng Wang, Chuntao Liu, et al.
Peerj|April 13, 2023
T cell receptor repertoire as a novel indicator for identification and immune surveillance of patients with severe obstructive sleep apneaKai Li, Yue Zhuo, Yue He, et al.
IEEE Journal of Biomedical and Health Informatics|August 20, 2024
3MT-Net: A Multi-modal Multi-task Model for Breast Cancer and Pathological Subtype Classification Based on a Multicenter StudyYaofei Duan, Patrick Cheong-Iao Pang, Ping He, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A <i>Post-hoc</i> Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled TrialRuchong Chen, Yuanrong Dai, Danrong Yang, et al.
Journal of Thoracic Disease|May 22, 2025
The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024]Nan Jia, Meiling Jin, Yun Liu, et al.
Plos One|January 13, 2021
Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, ChinaAlastair Heffernan, Yanling Ma, Shevanthi Nayagam, et al.
Journal of Gastroenterology|July 29, 2025
The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancerFeng Du, Xu Ji, Jiayi Su, et al.
BMC Infectious Diseases|August 10, 2021
Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, ChinaJianjiang Qi, Di He, Dagan Yang, et al.
QJM : Monthly Journal of the Association of Physicians|December 31, 2025
Efficacy and Safety of Intranasal Bencycloquidium Bromide in Nasal Symptoms of Common Cold: a Phase 3, Multicenter, Randomised, Double-blind, Placebo-controlled TrialLixiu He, Ling Yang, Haiying Yan, et al.
Pageof 9